Following atrial fibrillation patients after catheter ablation to study recurrence risk
Follows adults with atrial fibrillation treated by catheter ablation to study recurrence risks.
Plain-language title generated from the registry record
Registry title: Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with atrial fibrillation confirmed on an ECG or Holter recording, who are treated with catheter ablation at one hospital's cardiology department.
- Age
- Older than 18 years (minimum age 18 years).
- Sex
- All sexes can join.
- Disease stage
- Atrial fibrillation confirmed by an ECG or a Holter electrocardiogram.
Main reasons for not taking part
- Blood diseases, autoimmune diseases or cancer
- Cannot move because of hemiplegia or severe injury
- Expected survival of less than 2 years
- Poor compliance with the study and a high risk of being lost to follow-up
- Disorders of consciousness or Alzheimer's disease
Read by machine on 9 November 2026.
Where in China
- Peking University Third HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peking University Third Hospital
- Trial code
- NCT05638841
- Record updated
- 21 February 2024
- Original description
In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.Read full original descriptionShow less
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.
Inclusion: 1) Age > 18; 2) ECG or holter electrocardiogram confirmed atrial fibrillation.
Exclusion: 1) Hematological diseases, autoimmune diseases and malignant tumors; 5) Disorders of consciousness or Alzheimer's disease; 2) Immobility caused by hemiplegia or severe trauma; 3) The expected survival time is less than 2 years; 4) Poor compliance and high risk of expected loss of follow-up.